Japan pledges $130M to infectious disease fund

May 24, 2016 News BioVox

The Japanese government will invest an additional $130 million in the The Global Heath Innovative Technology (GHIT) Fund, which supports R&D on infectious diseases including malaria, tuberculosis, HIV and neglected tropical diseases.

The fund is a public-private partnership among seven Japanese pharmaceutical companies, the Japanese government, the Bill & Melinda Gates Foundation, the Wellcome Trust and the United Nations Development Program. The fund said it has invested more than $60 million in 60 development partnerships, and has started seven clinical trials in high-burden countries.

Japan’s Ministry of Health, Labor and Welfare (MHLW) and Ministry of Foreign Affairs each pledged Y700 million ($7.2 million) to help launch the fund in 2013.

Adapted from BioCentury

Avatar photo

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

All posts

Subscribe to the BioVox newsletter